Skip to content

About
- Technology
- Our Team
- Contact
- FAQ
Therapeutic Solutions
- Nutraceuticals
- CDMO Services
Our Competitive Advantage
- Clinical Studies
- Sustainability
News
Investors

About
- Technology
- Our Team
- Contact
- FAQ
Therapeutic Solutions
- Nutraceuticals
- CDMO Services
Our Competitive Advantage
- Clinical Studies
- Sustainability
News
Investors

BioHarvest Sciences launch of their flagship product Vinia has begun in the United States

← Previous Media Video

Next Media Video →

Search

Recent Posts

BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results
BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025
BioHarvest In Vitro testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells
BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD
BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar

Recent Comments

No comments to show.

Archives

Categories

2020
2021
2022
2023
2024
2025
Uncategorized

Join Our Newsletter

Be the first to receive our news alerts, event notifications, and product releases.

Revolution

Facebook X-twitter Linkedin Youtube

About
- Technology
- Our Team
- Contact
- FAQ
Therapeutic Solutions
- Nutraceuticals
- CDMO Services
Our Competitive Advantage
- Clinical Studies
- Sustainability
News
Investors